Interaction between N⁶-methyladenosine (m⁶A) modification and noncoding RNAs in cancer

Area of Science:

• Epigenetics
• Molecular Biology
• RNA Biology

Background:

• N6-methyladenosine (m6A) is a critical RNA modification in eukaryotes, influencing mRNA fate and cellular functions.
• m6A modification affects RNA splicing, export, translation, and stability, often mediated by noncoding RNAs.
• Noncoding RNAs, including microRNAs, long noncoding RNAs, circular RNAs, small nuclear RNAs, and ribosomal RNAs, are extensively modified by m6A and depend on it for their biogenesis and function.

Purpose of the Study:

• To discuss the intricate interactions between m6A modification and noncoding RNAs.
• To focus on the functional significance of m6A in cancer progression, metastasis, drug resistance, and immune response.
• To explore the potential of m6A regulatory proteins and their inhibitors for cancer diagnosis and treatment.

Main Methods:

• Review and synthesis of existing research on m6A modification and noncoding RNAs.
• Analysis of the role of m6A in various aspects of cancer biology.
• Discussion of therapeutic strategies targeting m6A pathways.

Main Results:

• m6A modification is integral to the biogenesis and function of diverse noncoding RNAs.
• m6A plays a significant role in cancer progression, metastasis, drug resistance, and immune evasion.
• m6A regulatory proteins and inhibitors present promising avenues for cancer therapy.

Conclusions:

• The interplay between m6A and noncoding RNAs is a key determinant of cancer phenotypes.
• Targeting m6A pathways, especially in conjunction with immunotherapy, holds potential for improved cancer treatment.
• Further investigation into m6A regulatory mechanisms is crucial for developing novel diagnostic and therapeutic interventions.